The efficacy of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma exhibiting primary resistance to front-line targeted therapy or immunotherapy

  • L. Hamieh
  • , R. L. Beck
  • , V. H. Le
  • , James J. Hsieh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)53-61
Number of pages9
JournalOnkourologiya
Volume16
Issue number3
DOIs
StatePublished - 2020

Cite this